Diagnostic pre-clinical services program -IDIQ - dynport
Active Awarded Last action
- Contract number
- 75N93023F00002
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,500
Award facts
- Contract value 100% obligated
- $3,500.00 Current and potential, with all options
- Completion date 48% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order award to Dynport Vaccine Company LLC (DVC), a subsidiary of General Dynamics Corp, under the $36 million Diagnostic Pre-Clinical Services Program IDIQ contract with the National Institute of Allergy and Infectious Diseases (NIAID). The task order is for a 7-year period of performance with a ceiling value of $3,500. It does not have a set-aside designation.
Under this contract, DVC will provide a range of research, development, manufacturing, and testing services to support the advancement of diagnostic products targeting infectious diseases. This includes processes such as assay validation, pilot manufacturing, and regulatory documentation. DVC has extensive experience supporting the preclinical and clinical development of biopharmaceuticals and diagnostics for NIAID, HHS, and the Department of Defense. The award leverages DVC's prior work under infectious disease-focused IDIQ contracts with NIAID, including the $30 million Preclinical Services for Biopharmaceutical Product Development IDIQ.
Quick answers
Who was awarded contract 75N93023F00002?
75N93023F00002 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2023.
How much is contract 75N93023F00002 worth?
The government has obligated $3,500 on 75N93023F00002.
Is contract 75N93023F00002 an order under another contract?
Yes. 75N93023F00002 is a delivery order under 75N93023D00016, an indefinite delivery contract.
Was contract 75N93023F00002 competed?
The extent of competition for 75N93023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award